Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised,...

por Chipps, Bradley E, Albers, Frank C, Reilly, Laurence, Johnsson, Eva, Cappelletti, Christy, Papi, Alberto
Publicado 2021

Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials

por Cappelletti, Christy, Maes, Andrea, Rossman, Kimberly, Gillen, Michael, LaForce, Craig, Kerwin, Edward M., Reisner, Colin
Publicado 2021

Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study

por Ferguson, Gary T., Papi, Alberto, Anzueto, Antonio, Kerwin, Edward M., Cappelletti, Christy, Duncan, Elizabeth A., Nyberg, Jack, Dorinsky, Paul
Publicado 2018

Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD

por Hanania, Nicola A., Papi, Alberto, Anzueto, Antonio, Martinez, Fernando J., Rossman, Kimberly A., Cappelletti, Christy S., Duncan, Elizabeth A., Nyberg, Jack S., Dorinsky, Paul M.
Publicado 2020